Erika Tamabuchi Selected Research

Retinoid X Receptors (Retinoid X Receptor)

1/2022

Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Tamabuchi Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 12/2023 - 02/2018
3	Neoplasms (Cancer) 04/2024 - 09/2021
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2023 - 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 12/2023
1	Uveitis 12/2023
1	Hemangiosarcoma (Angiosarcoma) 11/2023
1	Skin Neoplasms (Skin Cancer) 11/2023
1	Mycosis Fungoides 11/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2022
1	Rheumatoid Arthritis 05/2022
1	COVID-19 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Drug Eruptions (Drug Eruption) 01/2022
1	Monoclonal Gammopathy of Undetermined Significance 09/2021
1	Cutis Laxa 09/2021
1	Microcystic adnexal carcinoma 09/2021
1	Multifocal fibrosclerosis 06/2021
1	Localized Scleroderma (Morphea) 06/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Lichen Planus (Lichen Ruber Planus) 01/2021
1	Erythema 02/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2014
1	Seborrheic Keratosis 05/2014

Drug/Important Bio-Agent (IBA)

3	Bexarotene (LGD1069)FDA Link 06/2023 - 01/2022
2	pembrolizumabIBA 04/2024 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 05/2022
2	dabrafenibIBA 05/2022 - 02/2018
2	trametinibIBA 05/2022 - 02/2018
2	NivolumabIBA 01/2022 - 02/2018
1	HLA-DRB1*04 antigenIBA 12/2023
1	Proto-Oncogene Proteins B-rafIBA 12/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2023
1	Plasminogen Activator Inhibitor 1IBA 11/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	binimetinibIBA 05/2022
1	encorafenibIBA 05/2022
1	RetinoidsIBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 09/2021
1	PeriostinIBA 09/2021
1	Matrix Metalloproteinases (MMPs)IBA 09/2021
1	Immunoglobulins (Immunoglobulin)IBA 06/2021
1	InterferonsIBA 09/2014
1	Melanins (Melanin)IBA 05/2014

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2022
1	Drug Therapy (Chemotherapy) 12/2023
1	Phototherapy (Light Therapy) 06/2023
1	Radiotherapy 11/2022
1	Cryosurgery 05/2014